Related Experiment Video
Updated: Jun 26, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Sociodemographic determinants of Pulmonary Hypertension in a Tertiary Care Hospital in Southern India
Deepa Noronha1, Prasanna Mithra P2, Narasimha Pai D1
1Department of Cardiology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
Background:
Pulmonary hypertension (PH) is a progressive disorder with significant morbidity and mortality. Limited data exist on the demographics, echocardiographic profile, and quality of life of PH patients in the Indian population. The objective of this is to assess the demographics, clinical characteristics, echocardiographic parameters, and health-related quality of life (HRQoL) among patients with pulmonary hypertension across different WHO groups.
Methods:
This cross-sectional study included 114 patients diagnosed with pulmonary hypertension on echocardiographic criteria. This study aligns SDG 3 (Good Health and Well-being) by addressing non-communicable disease burden and highlighting sociodemographic disparities in pulmonary hypertension. Demographic and clinical data were recorded. Comprehensive echocardiographic assessment, including conventional measures and advanced indices such as RV tissue Doppler velocity and global longitudinal strain (GLS), was performed. HRQoL was evaluated using the EmPHasis-10 questionnaire. Intergroup comparisons were analyzed using one-way ANOVA.
Results:
The mean age was 57.1 ± 16 years, with a male predominance (64.9%). Group 2 PH (36%) was the most common etiology, followed by Group 1 PH (28.9%). Diabetes mellitus (68.4%) and hypertension (56.1%) were the most common comorbidities. RV function was impaired across all groups (mean TAPSE: 14.9 ± 4.42 mm; FAC: 34.2 ± 10.6%), with markedly reduced RV GLS (13.9 ± 5.2%). The RV tissue Doppler velocity differed significantly between the groups (p < 0.001). The mean EmPHasis-10 score was 42.2 ± 6.22, indicating substantial HRQoL impairment. Compared with the youngest group, patients in the oldest age group had greater than threefold greater odds of having severe disease (OR = 3.3, 95% CI: 1.0-10.6; p = 0.048).
Conclusion:
Pulmonary hypertension patients in this cohort presented with advanced functional limitations, high comorbidity burdens, and significant RV dysfunction. Older age is an independent predictor of severe disease. Advanced echocardiographic indices and HRQoL assessment provide valuable insights for early detection and comprehensive management.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
